Fermi financials
$4.28+0.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 |
| Gross margin | — | — |
| Operating income | -$26.8M | -$166.2M |
| Net income | -$25.8M | -$188.7M |
| Net margin | — | — |
| Diluted EPS | $-0.04 | $-0.30 |
| EBITDA | -$26.8M | -$166.2M |
| Operating cash flow | -$48.7M | -$7.3M |
| Free cash flow | -$233.6M | -$448.5M |
| Diluted shares | 637.3M | 629.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $62.5M | $207.5M | $408.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $520.1M | $421.3M | $109.8M |
| Total assets | $1.76B | $1.78B | $1.41B |
| Total liabilities | $731.5M | $705.2M | $317.4M |
| Shareholders' equity | $1.03B | $1.07B | $1.10B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology